Bis((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)methyl)amine

Catalog No.: 
ACEDRN354
CAS No.: 
1260811-27-5
Molecular Formula: 
C18H19NO4
Molecular Weight: 
313.35
Bis((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)methyl)amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$98.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBis((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)methyl)amine
IUPAC Namebis((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)methyl)amine
Molecular FormulaC18H19NO4
Molecular Weight313.35
SMILESC12=CC=C(CNCC3=CC=C4OCCOC4=C3)C=C1OCCO2
InChI KeyWJYOGHXICMZTOQ-UHFFFAOYSA-N
SynonymBis((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)methyl)amine;1,4-Benzodioxin-6-methanamine, N-[(2,3-dihydro-1,4-benzodioxin-6-yl)methyl]-2,3-dihydro-
CAS No.1260811-27-5
PubChem CID91667908

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACEDRN354 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSFYM195 route compound structure diagram
    ACSFYM19517413-10-4In Stock
  2. Plus
  3. ACGVAE261 route compound structure diagram
    ACGVAE26129668-44-8In Stock
  4. Then
  5. ACEDRN354 route product structure diagram
    ACEDRN3541260811-27-5
Inquiry

2. ACEDRN354 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACSFYM195 route compound structure diagram
    ACSFYM19517413-10-4In Stock
  4. Then
  5. ACEDRN354 route product structure diagram
    ACEDRN3541260811-27-5
Inquiry

3. ACEDRN354 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEDRN354 route product structure diagram
    ACEDRN3541260811-27-5
Inquiry

Comments (0)